Cryo-Cell International
CCEL
12 hedge funds and large institutions have $2.5M invested in Cryo-Cell International in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
2.19% less ownership
Funds ownership: 12.02% → 9.83% (-2.2%)
14% less funds holding
Funds holding: 14 → 12 (-2)
42% less capital invested
Capital invested by funds: $4.33M → $2.5M (-$1.82M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.97K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.93K |
| 3 |
BlackRock
New York
|
+$1.55K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$825K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.97K |
| 3 |
Morgan Stanley
New York
|
-$1.54K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$17 |
CCEL Hedge Fund Activity: Q1 2023 in Review
12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q1 2023, worth a combined $2.5M — down 42% from $4.33M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CCEL and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $5.97K. The largest seller was ISZO Capital Management, exiting entirely with an estimated $825K sold.
- 12 institutional investors held Cryo-Cell International (CCEL) as of Q1 2023, down from 14 in Q4 2022.
- Funds reported $2.5M of Cryo-Cell International stock for Q1 2023, down 42% quarter-over-quarter.
- 0 funds opened new Cryo-Cell International positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest Cryo-Cell International buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $5.97K added.
- The largest Cryo-Cell International seller in Q1 2023 was ISZO Capital Management, an estimated $825K sold.
Based on aggregated 13F filings for Q1 2023.